ReviewPathogens (Basel, Switzerland)2022
Prevalence of
Review in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Efficacy and safety of antibiotics for treatment of leptospirosis: a systematic review and network meta-analysis.Systematic reviews · 2024Pooled it
- Host diversity and landscape structure drive genospecies-specific Lyme disease risk across Eurasia.One health (Amsterdam, Netherlands) · 2026Article
- Distribution and Genetic Diversity ofPathogens (Basel, Switzerland) · 2026Article
- Review
- Global risk assessment of Lyme borreliosis transmission.Pathogens and global health · 2026Article
- Tick-Borne Co-Infection in Lyme Disease: Clinical Impact, Diagnostic Challenges, and Therapeutic Perspectives.Microorganisms · 2026Review
- Borrelial Diseases Across Eurasia.Biology · 2025Review
- Geographical Distribution and Prevalence of Borrelia Genospecies in Eurasian Ticks.Scientific data · 2025Article
- Distribution pattern and diversity of Borrelia spp. detected from ticks in Niigata prefecture, Japan.BMC research notes · 2025Article
- Prevalence of Lyme Disease and Relapsing FeverPathogens (Basel, Switzerland) · 2024Review
- The Role of Environmental Factors in Lyme Disease Transmission in the European Union: A Systematic Review.Tropical medicine and infectious disease · 2024Review
- Clinical Algorithm and Diagnostic Tools for Lyme Disease.Methods in molecular biology (Clifton, N.J.) · 2024Article
- Identifying Potential Lyme Disease Cases Using Self-Reported Worldwide Tweets: Deep Learning Modeling Approach Enhanced With Sentimental Words Through Emojis.Journal of medical Internet research · 2023Article
- Advances in the Epidemiological Surveillance of Tick-Borne Pathogens.Pathogens (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 1 institution in 1 country.
Funding
Abstract
Lyme disease (LD) is a common arthropod-borne inflammatory disorder prevalent in the northern hemisphere. LD is caused by a spirochete named
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.